Maria Jove

Barcelona, CT 08908, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study.

Reply to P. de Boissieu et al.

High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome.

Showing 1-9 of 9

Last Updated: 09/26/2026